Login / Signup

C-6α- vs C-7α-Substituted Steroidal Aromatase Inhibitors: Which Is Better? Synthesis, Biochemical Evaluation, Docking Studies, and Structure-Activity Relationships.

Fernanda M F RoleiraCarla VarelaCristina AmaralSaul C CostaGeorgina Correia-da-SilvaFederica MoracaGiosuè CostaStefano AlcaroNatércia A A TeixeiraElisiário J Tavares-da-Silva
Published in: Journal of medicinal chemistry (2019)
C-6α and C-7α androstanes were studied to disclose which position among them is more convenient to functionalize to reach superior aromatase inhibition. In the first series, the study of C-6 versus C-7 methyl derivatives led to the very active compound 9 with IC50 of 0.06 μM and Ki = 0.025 μM (competitive inhibition). In the second series, the study of C-6 versus C-7 allyl derivatives led to the best aromatase inhibitor 13 of this work with IC50 of 0.055 μM and Ki = 0.0225 μM (irreversible inhibition). Beyond these findings, it was concluded that position C-6α is better to functionalize than C-7α, except when there is a C-4 substituent simultaneously. In addition, the methyl group was the best substituent, followed by the allyl group and next by the hydroxyl group. To rationalize the structure-activity relationship of the best inhibitor 13, molecular modeling studies were carried out.
Keyphrases
  • structure activity relationship
  • molecular dynamics
  • neoadjuvant chemotherapy
  • lymph node
  • small molecule
  • rectal cancer